Stéphane Bancel, Moderna CEO (Charles Krupa/AP Images)
October 17, 2022 10:44 AM EDT
Coronavirus

Covid-19 roundup: Mod­er­na rewrites agree­ment with Gavi; Bavar­i­an Nordic touts PhII boost­er re­sults

Tyler Patchen

News Reporter

Mod­er­na is call­ing it quits on its cur­rent agree­ment with Gavi, the Vac­cine Al­liance, mean­ing an orig­i­nal deal for up to 500 mil­lion dos­es of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

A service from the Financial Times